Journal of Adolescent Health
Volume 42, Issue 5 , Pages 458-465 , May 2008

The Availability and Portrayal of Stimulants Over the Internet

  • Ty S. Schepis, Ph.D.

      Affiliations

    • Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut
    • Corresponding Author InformationAddress correspondence to: Ty S. Schepis, Ph.D., Department of Psychiatry, Yale University School of Medicine, 34 Park Street, Room S-213, New Haven, CT 06519.
    • ,
  • Douglas B. Marlowe, J.D., Ph.D.

      Affiliations

    • Treatment Research Institute, Philadelphia, Pennsylvania
    • Center for Studies of Addiction, University of Pennsylvania, Philadelphia, Pennsylvania
    • ,
  • Robert F. Forman, Ph.D.

      Affiliations

    • Treatment Research Institute, Philadelphia, Pennsylvania
    • Center for Studies of Addiction, University of Pennsylvania, Philadelphia, Pennsylvania
    • Alkermes, Inc., Cambridge, Massachusetts

Received 21 August 2007 ,Accepted 27 November 2007.

References 

  1. Medical Economics Company. Physicians' Desk Reference. 59th ed. Montvale, NJ: Medical Economics Company, Inc; 2005;
  2. Julien RM. A Primer of Drug Action: A Concise, Nontechnical Guide to the Actions, Uses and Side Effects of Psychoactive Drugs. 8th ed. New York: W.H. Freeman and Co; 1997;
  3. Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005;366:237–248
  4. Keating GM, Raffin MJ. Modafinil: A review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder. CNS Drugs. 2005;19:785–803
  5. 21 USC 801. Comprehensive Drug Abuse Prevention and Control Act. 1970.
  6. Compton WM, Volkow ND. Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend. 2006;83(Suppl 1):S4–S7
  7. Poulin C. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: Connecting the dots. Addiction. 2007;102:740–751
  8. Johnston LD, O'Malley PM, Bachman JG, et al. Monitoring the Future national survey results on drug use, 1975–2005. Volume I: Secondary school students. NIH Publication No. 06-5883. Bethesda, MD: National Institute on Drug Abuse; 2006;
  9. McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use and diversion of abusable prescription drugs. J Am Coll Health. 2006;54:269–278
  10. McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use and diversion of prescription stimulant medication. J Psychoactive Drugs. 2006;38:43–56
  11. Poulin C. Medical and nonmedical stimulant use among adolescents: From sanctioned to unsanctioned use. Can Med Assoc J. 2001;165:1039–1044
  12. Rushton JL, Whitmire JT. Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998. Arch Pediatr Adolesc Med. 2001;155:560–565
  13. Thomas CP, Conrad P, Casler R, et al. Trends in the use of psychotropic medications among adolescents, 1994 to 2001. Psychiat Serv. 2006;57:63–69
  14. Friedman RA. The changing face of teenage drug abuse—the trend toward prescription drugs. N Engl J Med. 2006;354:1448–1450
  15. Partnership for a Drug-Free America. The Partnership Attitude Tracking Study (PATS): Teens in grades 7 through 12, 2005. New York: 2006.
  16. McCabe SE, Boyd CJ. Sources of prescription drugs for illicit use. Addict Behav. 2005;30:1342–1350
  17. Substance Abuse and Mental Health Services Administration. Results from the 2005 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. SMA 06-4194. Rockville, MD: 2006.
  18. Wilford BB, Smith DE, Bucher R. Prescription stimulant sales on the Internet. Pediatr Ann. 2006;35:575–578581–2, 585–6
  19. Food and Drug Administration. FDA alerts consumers to unsafe, misrepresented drugs purchased over the Internet. Department of Health and Human Services, Washington, DC: February 16, 2007.
  20. Forman RF, Woody GE, McLellan T, et al. The availability of web sites offering to sell opioid medications without prescriptions. Am J Psychiatry. 2006;163:1233–1238
  21. Forman RF, Block LG. The marketing of opioid medications without prescription over the Internet. J Public Policy Marketing. 2006;25:133–146
  22. Fife-Yeomans J. Stimulating debate—Ritalin prescription rates for children are raising alarm bells. Daily Telegraph, April 28, 2007.
  23. Vedantam S. Millions have misused ADHD stimulant drugs, study says. Washington Post, February 25, 2006.
  24. Boyer EW, Shannon M, Hibberd PL. The Internet and psychoactive substance use among innovative drug users. Pediatrics. 2005;115:302–305
  25. Brewer NT. The relation of Internet searching to club drug knowledge and attitudes. Psychol Health. 2003;18:387–401
  26. Millon P. Penthouse lab busted in methamphetamine crackdown. Associated Press Newswires, November 30, 2006.
  27. Romanelli F, Smith KM. Clinical effects and management of methamphetamine abuse. Pharmacotherapy. 2006;26:1148–1156
  28. Google. Our search: Google technology. 2007 [Online; cited 2007 February 7]; Available at: http://www.google.com/technology/Last accessed November 6, 2007.
  29. Jansen BJ, Spink A, Pedersen J. A temporal comparison of AltaVista Web searching. J Am Soc Inform Sci Technol. 2005;56:559–570
  30. Jansen BJ, Spink A, Saracevic T. Real life, real users, and real needs: A study and analysis of user queries on the web. Inform Process Manag. 2000;36:207–227
  31. 21 CFR § 1308. Schedules of Controlled Substances. 2001.
  32. Federal Register: April 27, 2001, Volume 66, Number 82.21181–22118.
  33. Erowid. Erowid Experience Vaults: Amphetamines (Adderall). 2007 [Online; cited 2007 February 12]; Available at: www.erowid.org/experiences/exp.php?ID=34319Last accessed July 25, 2007.
  34. National Institute of Drug Abuse. Research Report Series–Prescription Drugs: Abuse and Addiction. NIH Publication No. 05-4881. Rockville, MD: National Institutes of Health; 2005;
  35. Ritter A, Cameron J. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs. Drug Alcohol Rev. 2006;25:611–624
  36. United States General Accounting Office. Internet pharmacies: Some pose safety risks for consumers (Report to the Chairman, Permanent Subcommittee on Investigations, Committee on Governmental Affairs, US Senate). (GAO Report No. 04-820) Washington DC: General Accounting Office; 2004;
  37. Hubbard WK. March 18 Washington, DC: U.S. House of Representatives hearing on Internet drug sales; 2004;
  38. Rannazzisi JT. DEA congressional testimony, written statement. Washington, DC, December 13, 2005.
  39. McCabe SE, Teter CJ, Boyd CJ. The use, misuse and diversion of prescription stimulants among middle and high school students. Substance Use Misuse. 2004;39:1095–1116
  40. McCabe SE, Teter CJ, Boyd CJ, et al. Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001. J Adolesc Health. 2004;35:501–504

PII: S1054-139X(07)00641-6

doi: 10.1016/j.jadohealth.2007.11.140

Journal of Adolescent Health
Volume 42, Issue 5 , Pages 458-465 , May 2008

Article Tools